Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Phase 4

Completed

• Conditions: Autoimmune Hepatitis
• Interventions: Drug: Treatment with mycophenolat mofetil; Drug: Treatment with azathioprin

• Registration Number: NCT00687180
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-05
• Study First Submitted: 2008-05-28
• Study First Submitted QC: 2008-05-29
• Last Update Submitted: 2008-05-29
• Study First Posted: 2008-05-30
• Last Update Posted: 2008-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• De novo autoimmune hepatitis
• Consent

Exclusion Criteria

• age below 18
• pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
I	Treatment with mycophenolat mofetil	MMF
II	Treatment with azathioprin	-

Trial Locations

Locations (1)

Rigshospitalet, Dept. of Hepatology A-2121; 🇩🇰 Copenhagen, Denmark